Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dodick

Showing results (331-340 of 620) with videos related to

Pageof 62
Sort By:
Surgical and Radiologic Anatomy : SRA|December 24, 2017
Depicting the pterygopalatine ganglion on 3 Tesla magnetic resonance imagesDaniel Fossum Bratbak, Mari Folvik, Ståle Nordgård, et al.
Advances in Therapy|December 7, 2021
Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 TrialsAndrew M Blumenfeld, Kerry Knievel, Aubrey Manack Adams, et al.
JAMA|November 20, 2019
Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical TrialRichard B Lipton, David W Dodick, Jessica Ailani, et al.
The New England Journal of Medicine|December 5, 2019
Ubrogepant for the Treatment of MigraineDavid W Dodick, Richard B Lipton, Jessica Ailani, et al.
Cephalalgia : an International Journal of Headache|September 24, 2019
Proposed new diagnostic criteria for chronic migraineMona Ameri Chalmer, Thomas Folkmann Hansen, Elena R Lebedeva, et al.
Cephalalgia : an International Journal of Headache|May 4, 2018
Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trialsRashmi B Halker Singh, Ernesto Aycardi, Marcelo E Bigal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 1999
Three-dimensional measurement of essential tremorJ Y Matsumoto, D W Dodick, L N Stevens, et al.
The Lancet. Neurology|August 22, 2020
Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trialPeter J Goadsby, David W Dodick, Jessica Ailani, et al.
Neuroscience and Biobehavioral Reviews|April 6, 2012
The young brain and concussion: imaging as a biomarker for diagnosis and prognosisEsteban Toledo, Alyssa Lebel, Lino Becerra, et al.
Neurology|November 26, 2009
Acgme, test thyself!D W Dodick, D Capobianco, K Kash, et al.
Pageof 62

Showing results (331-340 of 620) with videos related to

Sort By:
Pageof 62
Surgical and Radiologic Anatomy : SRA|December 24, 2017
Depicting the pterygopalatine ganglion on 3 Tesla magnetic resonance imagesDaniel Fossum Bratbak, Mari Folvik, Ståle Nordgård, et al.
Advances in Therapy|December 7, 2021
Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 TrialsAndrew M Blumenfeld, Kerry Knievel, Aubrey Manack Adams, et al.
JAMA|November 20, 2019
Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical TrialRichard B Lipton, David W Dodick, Jessica Ailani, et al.
The New England Journal of Medicine|December 5, 2019
Ubrogepant for the Treatment of MigraineDavid W Dodick, Richard B Lipton, Jessica Ailani, et al.
Cephalalgia : an International Journal of Headache|September 24, 2019
Proposed new diagnostic criteria for chronic migraineMona Ameri Chalmer, Thomas Folkmann Hansen, Elena R Lebedeva, et al.
Cephalalgia : an International Journal of Headache|May 4, 2018
Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trialsRashmi B Halker Singh, Ernesto Aycardi, Marcelo E Bigal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 1999
Three-dimensional measurement of essential tremorJ Y Matsumoto, D W Dodick, L N Stevens, et al.
The Lancet. Neurology|August 22, 2020
Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trialPeter J Goadsby, David W Dodick, Jessica Ailani, et al.
Neuroscience and Biobehavioral Reviews|April 6, 2012
The young brain and concussion: imaging as a biomarker for diagnosis and prognosisEsteban Toledo, Alyssa Lebel, Lino Becerra, et al.
Neurology|November 26, 2009
Acgme, test thyself!D W Dodick, D Capobianco, K Kash, et al.
Pageof 62